Literature DB >> 2280799

Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits.

G Eisenhofer1, H S Cox, M D Esler.   

Abstract

Rates of noradrenaline reuptake and spillover into plasma were examined in conscious rabbits before and during activation of the sympathetic nervous system to determine whether neuronal reuptake varies disproportionately or in parallel with increases in noradrenaline release. The sympathetic nervous system was stimulated by nitroprusside-induced hypotension, 2-deoxyglucose-induced glucopenia or intravenous infusion of isoprenaline before and after administration of desipramine to block neuronal uptake. Spillover of noradrenaline into plasma was estimated from the dilution of intravenously infused 3H-noradrenaline with endogenous plasma noradrenaline. The amount of dihydroxyphenylglycol (DHPG) in plasma that was derived from metabolism of recaptured noradrenaline, together with the desipramine-induced decreases in clearance from plasma of 3H-noradrenaline and appearance in plasma of 3H-DHPG, were used to estimate the rate of neuronal reuptake of noradrenaline. The mean (+/- SEM) resting noradrenaline reuptake rate (n = 28) was 0.62 +/- 0.04 nmol kg-1 min-1, 5-fold greater than the rate of its spillover into plasma (0.12 +/- 0.02 nmol kg-1 min-1). Intravenous infusion of nitroprusside at 3 rates titrated to cause graded increases in heart rate caused 74%, 129% and 240% increases in noradrenaline spillover into plasma and 66%, 104% and 198% increases in noradrenaline reuptake. At 15-30 min after intravenous injection of 2-deoxyglucose (500 mg/kg) there was a 106% increase in noradrenaline spillover and a 93% increase in noradrenaline reuptake. Infusion of isoprenaline (0.25 micrograms kg-1 min-1) caused a 102% increase in noradrenaline spillover and a 130% increase in noradrenaline reuptake.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2280799     DOI: 10.1007/bf00169445

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  22 in total

1.  Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.

Authors:  G Eisenhofer; D S Goldstein; R Stull; H R Keiser; T Sunderland; D L Murphy; I J Kopin
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

2.  Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

Authors:  D S Goldstein; G Eisenhofer; R Stull; C J Folio; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Haemodynamics as a determinant of the pharmacokinetics of and the plasma catecholamine responses to isoprenaline.

Authors:  J Ludwig; T Halbrügge; G Vey; J Walter; K H Graefe
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Dihydroxyphenylglycol as an index of neuronal uptake in dog saphenous vein.

Authors:  D K Rorie; L W Hunter; G M Tyce
Journal:  Am J Physiol       Date:  1989-12

5.  Tracer norepinephrine kinetics in coronary circulation of patients with heart failure secondary to chronic pressure and volume overload.

Authors:  C P Rose; J H Burgess; D Cousineau
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

6.  Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit.

Authors:  O S Medvedev; M D Esler; J A Angus; H S Cox; G Eisenhofer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

7.  Total body, systemic and pulmonary clearance and fractional extraction of unlabelled and differently 3H-labelled noradrenaline in the anaesthetized rabbit.

Authors:  T Halbrügge; A L Ungell; R Wölfel; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

8.  Pancreatic noradrenergic nerves are activated by neuroglucopenia but not by hypotension or hypoxia in the dog. Evidence for stress-specific and regionally selective activation of the sympathetic nervous system.

Authors:  P J Havel; R C Veith; B E Dunning; G J Taborsky
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

9.  Plasma catecholamine and hemodynamic responses during isoproterenol infusions in humans.

Authors:  D S Goldstein; R Zimlichman; R Stull; H R Keiser
Journal:  Clin Pharmacol Ther       Date:  1986-08       Impact factor: 6.875

10.  The effect of 2-deoxy-D-glucose and D-glucose on the efferent discharge rate of sympathetic nerves.

Authors:  A Niijima
Journal:  J Physiol       Date:  1975-09       Impact factor: 5.182

View more
  6 in total

1.  Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal man.

Authors:  D S Goldstein; A Breier; O M Wolkowitz; D Pickar; J W Lenders
Journal:  Clin Auton Res       Date:  1992-12       Impact factor: 4.435

2.  Exaggerated Vasoconstriction to Spontaneous Bursts of Muscle Sympathetic Nerve Activity in Healthy Young Black Men.

Authors:  Jennifer R Vranish; Seth W Holwerda; Benjamin E Young; Daniel P Credeur; Jordan C Patik; Thales C Barbosa; David M Keller; Paul J Fadel
Journal:  Hypertension       Date:  2017-12-04       Impact factor: 10.190

3.  Effects of catechol-O-methyltransferase inhibition on the plasma clearance of noradrenaline and the formation of 3,4-dihydroxyphenylglycol in the rabbit.

Authors:  T Halbrügge; B Friedgen; J Ludwig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

4.  Spontaneous bursts of muscle sympathetic nerve activity decrease leg vascular conductance in resting humans.

Authors:  Seth T Fairfax; Jaume Padilla; Lauro C Vianna; Michael J Davis; Paul J Fadel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-04       Impact factor: 4.733

5.  Regional changes in cardiac and stellate ganglion norepinephrine transporter in DOCA-salt hypertension.

Authors:  Erica A Wehrwein; Martin Novotny; Greg M Swain; Lindsay M Parker; Mohammad Esfahanian; John M Spitsbergen; Beth A Habecker; David L Kreulen
Journal:  Auton Neurosci       Date:  2013-08-31       Impact factor: 3.145

Review 6.  Sympathetic nerve function--assessment by radioisotope dilution analysis.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.